Abstract. Nasopharyngeal carcinoma (NPC) is the most commonly diagnosed head and neck malignancy and is prevalent worldwide. Previous studies have demonstrated the antitumor properties of cepharanthine hydrochloride (CH) in several human cancer cells. However, the action of CH in NPC cells has yet to be determined. In the present study, we investigated the effects of CH in human NPC cell lines including CNE-1 and CNE-2 on cell growth and apoptosis in vitro. Using MTT and ATP-tumor chemosensitivity assays it was found that CH inhibited cell viability. Additionally, flow cytometric and analysis electron microscopy revealed the inhibition of cell cycle progression and reduction of apoptosis, respectively, in human NPC cell lines including CNE-1 and CNE-2 in vitro. To identify the potential action mechanisms of CH, the cDNA microarray analysis results were confirmed by quantitative PCR analysis using a number of genes, including CDKN1A/P21, NR4A1/TR3 and DAXX. In total, 138 upregulated and 63 downregulated genes in CNE-2 cells were treated with CH. According to their biological function, the genes were classified as: i) cell cycle-related genes; ii) DNA repair-related genes; iii) apoptosis-related genes and iv) nuclear factor-κB (NF-κB) transcription factors signal pathways. The results of the present study showed that CH is a potential therapeutic agent against human NPC, and provide rational explanations and a scientific basis for the study of the development of CH in the treatment of NPC.
Introduction
Nasopharyngeal carcinoma (NPC) is the most common head and neck malignancy with a unique geographical and ethnic distribution, being particularly prevalent in Southern China and Southeast Asia (1) . As with most other types of cancers, the prognosis for NPC is strongly associated with the presenting stage (2) . Although NPC is extremely radiosensitive (3), metastasis is found in 7% of patients at initial diagnosis and 20% or more develop metastasis following treatment (4) . Moreover, the appearance of local or distant relapse determines a less favorable prognosis for these patients (5) . Chemotherapy is a crucial treatment for late stage NPC patients; however, the regimen is often not completed due to the severe side effects (6) . Chinese traditional medicines have a mild pharmaco logical action and have been utilized in tumor therapy via naturally occurring drugs (7) (8) (9) (10) . Cepharanthine hydrochloride (CH) is a biscoclaurine (bisbenzylisoquinoline) amphipathic alkaloid that is isolated from Stephania cepharantha Hayata (11) . CH has several pharmacological actions, including antiinflammatory (12) , anti-allergic (13) and immunomodulatory activities (14) in vivo. In anticancer investigations, CH exhibited multiple pharmacological actions, including potentiating the effects of antitumor agents (15) , inducing apoptosis (16, 17) and radiation sensitization (18, 19) , and reversing the multidrug resistance (20) (21) (22) . However, to the best of our knowlege, no studies have focused on the antitumor effects of CH on NPC.
In the present study, we initially investigated the effects of CH in human NPC cell lines, including CNE-1 and CNE-2, on cell growth and apoptosis in vitro, and demonstrated, to the best of our knowledge, for the first time that, CH exerts a potent anti-NPC effect by inhibiting cell growth and inducing apoptosis. To gain a global and deep insight into the molecular mechanisms for the anti-NPC action of CH, we performed cDNA microarray analysis to identify differentially expressed genes in response to CH in CNE-2 cells, which was confirmed by reverse transcriptase-quantitative PCR (RT-qPCR).
Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (both from Gibco, Grand Island, NY, USA), 100 µg/ml penicillin and 100 U/ml streptomycin (Harbin Pharmaceutical Group Co., Ltd., Harbin, China). CH was purchased from the College of Life Science and Technology of jinan University (Guangzhou, China) and dissolved in a physiologic saline as a stock solution. CNE-1 and CNE-2 cells were treated with various concentrations (5, 10, 20, 40, 60 and 80 mg/l) of CH for the indicated durations (24, 48, 72 and 96 h). Control cells were treated with saline only.
MTT assay. CNE-1 and CNE-2 cells were seeded at a density of 2x10 4 cells/well in 96-well plates overnight and treated with various concentrations of CH for different periods of time as indicated. Then, 20 µl of 5 mg/ml of 3-(4,5-dimethyl thiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma, St. Louis, MO, USA) was added to each of the culture wells, and the plates were incubated for another 4 h. Following medium removal, 100 µl of DMSO was added to each well and plates were gently agitated for 15 min to dissolve all crystals. Optical absorbance was determined at 490 nm using an ELISA microplate reader (Tecan, Männedorf, Swiss).
ATP-tumor chemosensitivity assay. Cells (100 ml) (2x10 4 cells/ml) were seeded in 96-well plates for 24 h at 37˚C with 5% CO 2 , and treated with phosphate-buffered saline (PBS) as the control or 50% inhibiting concentration (IC 50 ) of CH (12.5 and 20.0 mg/l for CNE-1 and CNE-2 cells, respectively) for 24-96 h. At the end of the culture period, 50 ml with ATP extraction reagent (DCS Innovative Diagnostik Systeme, Hamburg, Germany) was added to the cells. The 100 µl aliquots of the lysates from each well were transferred into the corresponding wells of the new 96-well plates, and then 20 µl luciferin-luciferase reagent (DCS Innovative Diagnostik Systeme) was added into each well. In addition, we added 120 ml PBS in the blank well as the blank control. The light output corresponding to the level of ATP present was measured in a luminometer (Berthold Technologies, Bad Wildbad, Germany) and the growth inhibition was calculated using the formula: Growth inhibition percentage (%) = (M c -M t )/(M c -M b ) x 100, where M c , M t and M b stand for results of the control, test and blank groups, respectively.
Cell cycle analysis. CNE-1 and CNE-2 cells were treated with saline or the IC 50 of CH for 48 h, and then collected by centrifugation and rinsed twice with PBS. The cells were fixed in 70% ethanol and centrifuged again. The cells were stained with propidium iodide solution (50 mg/l) containing 1 mg/l of RNase A (both from Sigma) for 30 min at 37˚C. After incubation, the stained cells were rapidly analyzed using a FACScan flow cytometer (BD Biosciences, San Jose, CA, USA).
Electron microscopic analysis of cell apoptosis. Briefly, CNE-1 and CNE-2 cells, which were treated with saline or the IC 50 of CH for 48 h, were collected and washed twice in 0.1 mol/l phosphate buffer (pH 7.4) by centrifugation. The cell agglomerate of CNE-1 and CNE-2 cells were immersed in 0.1 mol/l phosphate buffer (pH 7.4) with 2.5% glutaraldehyde for 2 h at least, then post-fixed with 1% osmium tetroxide in 0.1 mol/l phosphate buffer (pH 7.0) for 30 min. After dehydration in a graded series of acetonum, the samples were embedded in Epon 812 at room temperature overnight. Ultrathin sections were cut, mounted on copper grids, and stained with uranyl acetate and lead citrate using standard methods. Stained grids were examined and photographed using a transmission electron microscope (TEM) (Hitachi, Toyko, japan).
cDNA microarray analysis cDNA microarray construction. The cDNA microarray was manufactured by the Shanghai Biochip Co., Ltd., China. Briefly, the human genes assessed in the present study, contained 16,450 unigenes (including 10-positive control and 6-negative control cDNAs), which were associated with various cell functions and signaling pathways, involving cell cycle, DNA repair, apoptosis, metabolism, cytoskeleton, proinflammatory effect, signaling transduction, and transcription factor.
RNA preparation, reverse transcription, probe construction and hybridization. CNE-2 cells were exposed to saline or IC 50 CH for 24 h, and total RNA was extracted using a qiagen RNeasy ® kit (qiagen, Hilden, Germany) according to the manufacturer's instructions. The quality of total RNA was assessed by agarose gel electrophoresis.
During the reaction of cDNA, Cy3/Cy5-dUTP was incorporated into the cDNA of the control and treatment sample, respectively. Briefly, total 10 µl solution including 3 µg random primer and 50 µg of total RNA from untreated and CH-treated cells was added into the PCR tube and degenerated, respectively, at 70˚C for 10 min. Then, 1.0 µl Cy3/Cy5-dUTP (1 mM) (Amersham Biosciences, Piscataway, Nj, USA), 1.0 µl SuperScript Ⅱ (200 U/ µl) (Invitrogen-Life Technologies, Carlsbad, CA, USA) were added into the tube to construct the reverse transcription reaction system, which was incubated for 2 h at 42˚C, degenerated for 5 min at 70˚C in the dark and terminated by 2 µl NaOH (2.5 M). The probe was purified according to the qIAquick Nucleotide Removal kit (qiagen), quantified and stored at -20˚C in vacuum.
For hybridization, 30 pmol Cy3/Cy5 labeling probe with a total volume up to 9 µl was added into the tube and degenerated for 3 min at 94˚C. Then, 2 µg human Cot-1 DNA (Invitrogen-Life Technologies) was added into the tube and incubated for 45 min at 70˚C. The previously prepared solution was mixed with 10 µl 4X hybridization solution and 20 µl methylamine to a final volume of 40 µl. Hybridization was titrated in microarray and carried out at 42˚C for 16-18 h in the dark and moist box. Following completion of hybridization, the microarray was washed with 1X SSC/0.2% SDS wash buffer for 10 min at 55˚C, 0.1X SSC/0.2% SDS wash buffer for 10 min at 55˚C twice, 0.1X SSC wash buffer for 5 min twice and ddH 2 O for 2 min at room temperature, and was dried by centrifugation at 1,500 rpm for 5 h.
Microarray data analysis. Microarray images from two-color fluorescent hybridization were scanned with an Agilent scanner (Agilent Technologies, Inc., Santa Clara, CA, USA). The scanning results were analyzed using ImaGene software (BioDiscovery, Hawthorne, CA, USA), and normalized using GeneSpring software; Silicon Genetics, Redwood City, CA, USA). Fluorescent images were gridded to locate the spot corresponding to each gene. Raw gene expression data were generated for each gene. The fold-change of each probe was calculated from the two dye-swap arrays, and the probes with ≥2-fold change in one assay and ≤0.5-fold in its dye-swap were considered to have a statistically significant change in gene expression.
Clustering analysis was carried out to classify the differentially expressed genes based on the similarity of the functions using GeneSpring software. The order can be observed according to the functions of differentially expressed genes.
RT-qPCR.
The same batches of total RNA from untreated and CH-treated CNE-2 cells for cDNA microarray were utilized for the synthesis of first-strand cDNA. The specific primer sequences and the expected amplicon size for GAPDH, CDKN1A, NR4A1 and DAXX are shown in Table I . RT-qPCR was performed using a SYBR-Green reaction mixture in the ABI 7300 detection system (Applied Biosystems, Foster City, CA, USA). The amplification program used was: one cycle at 50˚C for 2 min and 95˚C for 10 min; followed by 40 cycles at 95˚C for 15 sec and 60˚C for 1 min. The gene expression data were normalized to the endogenous control GAPDH. The relative gene expression levels were measured according to the formula 2 -ΔΔCt . The samples were run in triplicate and repeated twice.
Statistics analysis. SPSS software version 18.0 (SPSS, Inc., Chicago, IL, USA) was used for all statistical analyses by means of t-test, factor analysis and one-factor analysis of variance. The data in the tables and figures were publicized in the form of mean or mean ± standard deviation (SD). P<0.05 was considered to indicate a statistically significant result.
Results
Effects of CH on cell growth. After CNE-1 and CNE-2 cells were exposed to CH at various concentrations ranging from 5.0 to 80 mg/l for 24-96 h, cell viability was determined using the MTT assay. We observed that CNE-1 cells treated with CH presented a dose-and time-dependent decrease in cell viability when compared with the untreated cells (Fig. 1A) . CNE-2 cells exhibited a dose-but not time-dependent effect in response to CH ranging from 5.0 to 60.0 mg/l (Fig. 1B) . The median IC 50 values of CH for CNE-1 and CNE-2 cells calculated after 48 h treatment were 12.5 and 20.0 µg/ml, respectively. To confirm the cytotoxic effect of CH, we performed an ATP-tumor chemosensitivity assay to determine the inhibition ratio (IR) of CNE-1 and CNE-2 cells in response to IC 50 of CH for 24-96 h. The data (Table II) were in accordance with the MTT results. These results indicated that CH effectively inhibited CNE-1 and CNE-2 cell growth.
Effects of CH on cell cycle progression. To determine whether CH impaired the cell cycle of CNE-1 and CNE-2 cells, flow Table III , 48 h after treatment with IC 50 of CH apparently retarded CNE-1 and CNE-2 cells to enter the S phase. This result clearly suggested that the growth inhibitory effect of CH in CNE-1 and CNE-2 cells resulted from cell cycle arrest in the G 1 phase.
Effects of CH on cell apoptosis. TEM, which is one of the best methods to observe cell morphology including cytoplasm, organelle and nuclei, was used to confirm apoptosis of CNE-1 and CNE-2 cells treated with PBS or with IC 50 of CH for 48 h. As shown in Fig. 2A and C, there were no typical morphological changes indicative of apoptosis in the controls of CNE-1 and CNE-2 cells. By contrast, when CNE-1 and CNE-2 cells were exposed to IC 50 of CH for 48 h, typical apoptotic morphological changes were observed ( Fig. 2B and D) .
cDNA microarray profile of CNE-2 cells in response to CH.
To gain a global understanding of the pharmacological mechanism of CH in NPC cells, the cDNA microarray technique was used to establish the gene expression profiles of CNE-2 cells untreated or treated with CH. Signals were invisible in the blank spots, while the housekeeping gene density was similar, indicating that the results were credible. Preliminary results showed that the expression levels of 499 genes were significantly altered by CH in CNE-2 cells (Fig. 3) . After rejecting some complicated data, we found that there were 144 upregulated and 63 downregulated genes in the CH-treated CNE-2 cells. According to their attributes and functions in the biological processes, these differentially expressed genes may be classified as: i) cell cycle-related, ii) DNA repair-related, iii) apoptosis-related genes, and iv) nuclear factor-κB (NF-κB) transcription factors signal pathways. The segmental different genes associated with growth inhibition are shown in Table IV .
RT-qPCR analysis of several differentially expressed genes. To verify the data gained from cDNA microarray, three interesting genes, i.e., CDKN1A (NM_000389), NR4A1 (NM_002135) 
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and DAXX (NM_001350) (function and mapping information are presented in Table V) , were selected for RT-qPCR analysis.
As shown in Table VI and Fig. 4 , although some variability on the individual gene expression changes existed, a consistent differential expression trend was evident in the results from cDNA microarray and those from RT-qPCR.
Discussion
Nasopharyngeal carcinoma (NPC) is the most common head and neck malignancy within southern China and southeast Asia. Chemotherapy is crucial for late stage NPC patients. Nevertheless, treatment is often not completed due to the serious side effects caused (6). Chinese traditional medicines, which possess an anticancer function have been utilized in tumor therapy via naturally occurring drugs. Cepharanthine hydrochloride (CH), which is known as a membrane-interacting agent that has membrane-stabilizing activity, is a biscoclaurine alkaloid extracted from the roots of Stephania cepharantha Hayata and possesses plenty pharmacological activities (12) (13) (14) . Evidence suggests that CH potentiates the activity of certain anticancer agents (15) (16) (17) and restores the effect of anticancer drugs in multidrug/radioresistant cancer cells (18) (19) (20) (21) (22) . In the present study, we investigated whether CH affected CNE-1 and CNE-2 cell growth. The results show that there was a dose-and time-dependent decrease on the CNE-1 cell treated with CH, whereas only dose-dependent relationships were identified with CNE-2. At the same time, we assessed the effects of CH on the growth of CNE-1 and CNE-2 cells by means of an ATP-tumor chemosensitivity assay, the results of which were consistent with those of the MTT assay. Carcinomas are known to undergo an uncoordinated proliferation. Thus, we carried out cell cycle analysis and cell apoptosis detection. The results show that CH retarded the cell cycle and promoted the apoptosis of CNE-1 and CNE-2 cells. Tumor proliferation is associated with numerous growth regulatory genes in a multistep process of carcinogenesis and neoplasm progression. Gene expression is able to characterize the adaptation of cells to changes in an external environment and is also a sensitive indicator of toxicant exposure. To examine the intimate pharmacological molecular mechanism of the anti-NPC of CH, using cDNA microarray we identified that CH functions by cell cycle-related genes such as CDKN1A, ID1, CCNF, UNG2 and CBX7; DNA repaired-related genes such as XRCC1, RAD51L3 and NCOA6; and apoptosis-related genes such as NR4A1, DAXX, GADD45α, TNFRSF10b and DFFB. The results of RT-qPCR are consistent with the results of the cDNA microarray in the expression of differential genes (including CDKN1A, NR4A1 and DAXX) and show that the results of cDNA microarray are credible.
Cell cycle --------------------------------------------------------------------------------------------------------------
Cell cycle association genes. The cell division cycle is an important factor regulating cancer growth. In normal cells, the division cycle has been divided into G 1 , S, G 2 and the M phases. Cells that do not divide are deemed to be in the G 0 phase. When cells receive external stimulation to initiate division, they changed from the quiescent state into the cell division. A basic strategy when evaluating anticancer drugs is to arrest the cell cycle. In the present study, we found that CH of the 48 h IC 50 arrested the CNE-1 and CNE-2 cells from entering S phase and interfering with the proliferation of CNE-1 and CNE-2 cells when compared to the untreated cells. The cell cycle control system includes the cyclin-dependent kinases (CDKs), cyclins and cycledependent kinases inhibitors (CDKIs). The interactions of CDKs and cyclins can induce cell division; however, CDKIs inhibit the cell cycles. As shown in Table IV , we found upregulation of the proliferation stimulator (for example CDKN1A and CDKN2B) and downregulation of the proliferation inhibitor (for example ID1, CCNF, UNG2 and CBX7) in our investigation plays a direct role in CNE-1 cell proliferation following CH treatment. p21, which is known as a cyclin-dependent kinase inhibitor 1 or CDK-interacting protein 1, is a protein that is encoded by the CDKN1A gene located on chromosome 6 (6p21.2) in humans. The p21 protein binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes, and thus functions as a regulator of cell cycle progression at G 1 phase (22, 23) . The expression of this gene is closely controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G 1 phase arrest in response to a variety of stress stimuli (22, 23) . In our experiment, we identified the overexpression of p21 by cDNA microarray in NPC cells treated with CH. Thus, p21 inhibits the proliferation of NPC cells treated with CH.
ID1 gene is a type of downregulation of the proliferation inhibitor that was found by cDNA microarray. The ID1 gene encodes a type of positive regulator, a helix-loop-helix (HLH) protein that forms heterodimers with members of the basic HLH family of transcription factors and inhibits the DNA binding and transcriptional activation ability of basic HLH proteins with which it interacts. Evidence has shown that ID1 is able to promote cell proliferation and cell cycle progression through the inactivation of tumor suppressor pathways (24) . In addition, the overexpression of ID1 suppresses the expression of p21 by means of the bond with its promoter-E box (25) . The downregulation of ID1 is able to block the proliferation of NPC cells treated with CH. The mechanisms of p21 under the control of ID1 and E box may play a vital role in the arrest of NPC cells treated with CH.
DNA repair association genes. In the process of cell division, the human stable genome guarantees smooth cell proliferation. On the other hand, unstable genome is characteristic of cancer cells and accelerates broken and deformed chromosomes in the process of cancer cell division. If genetic abnormalities cannot be repaired, cell cycle restraint or apoptosis is triggered in the process of cancer cell division. DNA repair-related genes are employed to correct such drawbacks. In the present study, we found CH induces the downregulation of DNA repair genes (26) . The RAD51L3 gene is another downregulated gene derived from DNA repair genes. It encodes a member protein of the RAD51 protein family that is known to be involved in the homologous recombination and repair of DNA. This protein forms a complex with several other members of the RAD51 family, including RAD51L1, RAD51L2 and XRCC2. The protein complex formed with this protein has been shown to catalyze homologous pairing between single-and double-stranded DNA, and is thought to play a role in the early stage of recombinational repair of DNA (27) . We consider that downregulation of the DNA repair genes such as XRCC1, RAD51L3 and NCOA6, is associated with the functions of CH in NPC cells. Following treatment of NPC cells with CH, upregulation of the proliferation stimulator (for example CDKN1A and CDKN2B) and downregulation of the proliferation inhibitor (for example ID1, CCNF, UNG2 and CBX7) may play a direct role in the inhibition of NPC cell proliferation and block NPC cell cycles by their signal pathway. In the process of cell cycle arrest, the damaged DNA of NPC cells induced by CH need to be repaired and escape the checkpoint of cell cycles. However, the downregulation DNA repair association genes inhibits DNA repair and proliferation, and cell apoptosis association genes via CH induce NPC cell apoptosis.
Cell apoptosis association genes. The word 'apoptosis' comes form the Greek word meaning 'falling leaves' and was first used to describe a new form of cell death distinct from necrosis. Apoptosis is the morphologic appearance of programmed cell death which is an important mechanism in embryonic development, neurodegenerative diseases and homeostasis (28) . However, the dysregulated apoptosis is a crucial step in tumorigenesis (28) . Concerning cancer therapy, the ultimate purpose of cytotoxic therapies is to induce apoptosis or death of tumor cells. In the present study, typical apoptotic morphological changes were observed in these cells when the cells were exposed to IC 50 CH for 48 h. This showed the ability of CH to induce apoptosis. The process of apoptosis involves numerous genes. We found CH induces the expression of apoptotic genes (for example NR4A1, DAXX, GADD45α and TNFRSF10b). NR4A1 is a member of the steroid/thyroid/retinoid nuclear receptor superfamily. During apoptosis, NR4A1 expression is rapidly induced and plays roles in regulating growth and apoptosis in cancer cells. NR4A1 binding to the Bcl-2 N-terminal loop region and resulting in a conformational change in Bcl-2 can convert Bcl-2 from a protector to a killer protein (29) . In the present study, we found that the expression of NR4A1 in NPC cells treated with CH was 3.238-and 4.537-folds, respectively, compared with the control group in the cDNA microarray test and RT-qPCR. The overexpression of NR4A1 plays an important role in the apoptosis of NPC cells treated with CH.
DAXX, which links the death receptor to the c-jun amino-terminal kinase pathway, is another protein associated with apoptosis. DAXX negatively regulates apoptosis at the early embryonic stages (30) and cancer cells (31) via the p53 pathway. The downregulation of DAXX induced by CH may be one of the pathways leading to apoptosis in NPC cells.
GADD45, which responds to environmental stresses and the anticancer activity of chemotherapeutic agents, is an apoptosis-related gene mediated by p53 and the p53 homologues in our study. After DNA is damaged, the GADD45 protein family members are induced rapidly, participate actively in DNA repair mechanisms, and result in cell cycle arrest and/or apoptosis (32) . Evidence has also been provided that drug therapies act to directly or indirectly upregulate GADD45α and GADD45β and promote cancer cell apoptosis. In the present study, we found that CH induces the upregulation of GADD45α and GADD45β in NCP cells. As GADD45α and GADD45β are essential components of numerous metabolic pathways that control proliferation and induce cancer cell apoptosis, they may be regarded as emerging drug targets in NPC cells treated with CH.
Control group Test group --------------------------------------------------------------------------------------------------------------------------------------------------------------
Nuclear factor-κB transcription factor signaling pathways. Nuclear factor-κB (NF-κB) transcription factor signaling pathways are central components of immune responses and inflammatory. Evidence suggests that NF-κB signaling pathways that are involved in its activation are also important for tumor development. NF-κB is a negative regulator of cell proliferation (33) and a positive activator of anti-apoptotic genes (34) . TNFAIP3 is a key negative regulator of the NF-κB signal, through a wide variety of cell surface receptors and viral proteins. Previous findings have shown that TNFAIP3 reduces cell proliferation (35) and induces the apoptosis of cancer treated with chemotherapeutics (36) (37) (38) . In the present study, similar results were obtained whereby TNFAIP3 was upregulated by CH, reduced proliferation and induced NPC cell apoptosis.
In conclusion, to the best of our knowledge, we report for the first time that CH inhibited cell proliferation and induced apoptosis in NPC cells. The cDNA microarray analysis revealed that the anti-NPC action of CH may be mediated by regulating the expression levels of a variety of genes involved in cell cycle regulation, DNA repair, cell apoptosis and the NF-κB signaling pathway. Our findings provide a rational and scientific basis for the further study and development of CH as a potentially useful agent for NPC therapy, although more in-depth investigations are required.
